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ABSTRACT  Monoclonal antibodies were produced against the recently described short chain 
cartilage collagen (type X collagen), and one (AC9) was extensively characterized and used for 
immunohistochemical  localization  studies on  chick  tissues. By competition  enzyme-linked 
immunosorbent assay, antibody AC9 was observed to bind to an epitope within the helical 
domain of type X collagen  and did not react with the other collagen  types tested, including 
the  minor  cartilage  collagens  la,  2a,  3a,  and  HMW-LMW.  Indirect  immunofluorescence 
analyses with this antibody were performed on unfixed cryostat sections from various skeletal 
and nonskeletal tissues. Only those of skeletal origin showed detectable reactivity. Within the 
cartilage  portion of the 13-d-old embryonic tibiotarsus (a developing long bone) fluorescence 
was observed only in that region of the diaphysis containing hypertrophic chondrocytes. None 
was detectable in adjacent regions or in the epiphysis. Slight fluorescence was also present 
within the surrounding sleeve of periosteal  bone. Consistent with these results, the antibody 
did not react with the cartilages of the trachea and sclera, which do not undergo hypertrophy 
during the stages examined. It did, however, lightly react with the parietal  bones of the head, 
which  form  by  intramembranous  ossification.  These  results are  consistent with  our earlier 
biochemical analyses, which showed type X collagen  to be a product of that subpopulation 
of chondrocytes that have undergone hypertrophy. In addition, either it or an immunologically 
cross-reactive  molecule is also present in bone, and exhibits a diminished fluorescent intensity 
as compared with hypertrophic cartilage. 
During much of  embryonic development, and throughout the 
juvenile growth period, elongation of skeletal elements occurs 
chiefly by endochondral bone  formation in  the  epiphyseal 
growth region. This process involves precise temporal and 
spatial  changes in the deposition of new extracellular mate- 
rials, largely of a cartilagenous nature, as well as degradation 
and removal of  pre-existing matrices. These changes in matrix 
materials reflect differences in the cell populations present. In 
the growth region, chondrocytes undergo changes in which 
they sequentially progress through phases of rapid prolifera- 
tion, extensive matrix synthesis,  hypertrophy, and ultimate 
removal. Although these changes occur in an uninterrupted 
continuum,  it  has  been  demonstrated  using  the  12-d-old 
embryonic chick tibiotarsus that the epiphyseal growth region 
can be reproducibly subdivided into four zones (1). The cell 
populations in each zone are highly enriched for chondrocytes 
in one of the stages of this continuum, as determined by both 
biochemical and morphological criteria (2, 3). 
Initially, the only collagenous molecule detected in mature 
cartilage was type II (4, 5). This was also found to be the case 
during embryonic development (6-8), although some results 
suggested  that additional cartilage collagens  might exist (9). 
Further  biochemical  studies  definitively demonstrated  the 
existence of at least  three other genetically distinct types of 
collagen in cartilage (10-12). 
Some of these quantitatively "minor cartilage collagens" 
have been localized within the cartilage matrix ( 13-15). Ra- 
diolabeling experiments performed on cell and organ cultures 
of chondrocytes obtained  from  the  different zones of the 
epiphyseal growth region in the embryonic chick tibiotarsus 
suggested that at least one of these collagens was synthesized 
preferentially, if not exclusively, in the zone of hypertrophy. 
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collagen molecule (12,  16,  17), has been termed short chain 
cartilage collagen (12).  We would now like to designate it as 
collagen type X, in accordance with previously accepted no- 
menclature (18). A similar, if not identical, molecule has been 
identified by several other investigators (19-22). 
In mass cultures of passaged chondrocytes from the more 
mature zones of the embryonic tibiotarsus, type X  becomes 
the predominant collagenous molecule secreted into the cul- 
ture medium (12).  From this source, it can be obtained in 
relatively large  quantities  without  the  need  for proteolytic 
extraction procedures. The molecule contains both a collagen- 
ase-sensitive, triple helical domain and a pepsin-sensitive non- 
helical one. The complete molecule, with both domains intact, 
is referred to as the  59K ~ form since its constituent chains 
have an Mr of 59,000, as determined by SDS PAGE. Limited 
pepsin digestion of the nature 59K form removes the nonhel- 
ical domain, generating a  molecule with Mr-45,000  chains, 
termed the 45K form. Results in good agreement with these 
are obtained when rotary-shadowed preparations of the two 
forms of the molecule are examined by electron microscopy 
(17). 
Although the helical domain of type X is unusually small, 
it is also unusually stable. The denaturation temperature of 
the helical structure in both forms of  the molecule, as analyzed 
by circular dichroism (CD) spectropolarimetry at 222 nm, is 
~47°C, a temperature that is considerably higher than that of 
most collagen molecules (23).  This shows that type X  can 
exist within the extracellular matrix as a triple helical molecule 
and provides additional evidence that it is not a breakdown 
product of a larger molecule. 
In the present study, we report the production of a mono- 
clonal antibody specific for a  conformation-dependent epi- 
tope located within the helical domain of type X  collagen. 
We also employ this antibody for immunohistochemical stud- 
ies which  suggest  that type X  collagen is a  skeletal-specific 
molecule. In cartilage it is indeed restricted to the zone of 
hypertrophying chondrocytes  as  our  previous  biochemical 
analyses suggested.  It is also present in lesser amounts in bone 
derived from both endochondral and intramembranous ossi- 
fication. It is not, however, found in detectable amounts in 
any nonskeletal tissue examined. These results are consistent 
with and extend our previous observations on type X collagen. 
MATERIALS  AND  METHODS 
Collagen  Production:  The 59K form of  type X collagen was purified 
from the culture medium of chondrocytes that had been maintained  in mon- 
olayer culture for 6 wk, as previously described (12). The collagen was precip- 
itated from the medium by the addition  of solid ammonium sulfate to 30% of 
saturation (176 mg/ml) in the presence of protease inhibitors (5 mM EDTA,  l 
mM phenylmethylsulfonyl fluoride, l mM N-ethylmaleimide). The precipitate 
was recovered by centrifugation  (10,000 g  for 30  min) and resolubilized in 
potassium  phosphate  buffer (0.13 M K2HPO4, 5 mM KH2PO4, pH 7.6). The 
ammonium sulfate precipitation  was repeated a second time. Contaminating 
type II collagen was removed by dialysis against 0.5 M acetic acid, 0.9 M NaCl, 
under which conditions it precipitates. Type X collagen was then recovered by 
precipitation  by raising the NaCl concentration  to 2.0 M. The 45K  form of 
type X was generated by limited pepsin digestion of  the 59K form, as previously 
described (12). 
1  Abbreviations used in this paper:  CD, circular dichroism; ELISA, 
enzyme-linked immunosorbent assay; HMW and  LMW,  high and 
low  molecular  weight  collagen,  respectively;  59K  and  45K,  the 
M~-59,000 complete form and the Mr-45,000 helical form of type X, 
respectively. 
Hybridoma Production:  Female  SJL/J mice (The Jackson Labora- 
tory, Bar Harbor, ME) were each immunized subcutaneously with 200 #g of 
the 59K form of type X collagen in 200 ul of an emulsion containing complete 
Freund's adjuvant.  Equal volumes of adjuvant  and collagen solution  in PBS 
(137  mM NaCl, 2.7  mM  KCI, 8.1  mM NazHPO4, 1.5  mM KH2PO4) were 
mixed in two connecting syringes. The mixture was then sonicated for 5 s. The 
mice were boosted 2 wk later with a second subcutaneous  injection of 200 #g 
in incomplete  adjuvant  and then were rested for 6  too.  Prior  to the fusion 
procedure, the mice received four daily intraperitoneal  injections of 100 #g of 
type X in PBS without adjuvant. Their spleens were removed on the fifth day. 
The procedure used for the production  of hybridomas is described elsewhere 
(24) and is briefly summarized  here. All cultures of hybridomas and the NS-1 
myeloma  cells used  for  hybridoma  production  were  grown  in  Dulbecco's 
modified  Eagle's  medium  (4.5 g/liter  glucose  [Gibco  Laboratories,  Grand 
Island, NY]) supplemented with 10% fetal calf serum (Sterile Systems, Logan, 
UT) and gentamycin (50 gg/ml). Splenocytes (3 x  l0  T) were obtained from the 
immunized  mice and fused with NS-l  myeloma cells (10  T) in 37.5% polyeth- 
ylene glycol. The cells were suspended in complete medium and plated in 96- 
well culture plates at a density of 2.5  x  l04 myeloma cells per well. The next 
day,  hypoxanthine/aminopterin/thymidine medium was added  to select for 
hybridomas. 
Hybridomas were selected by enzyme-linked immunosorbent  assay (ELISA) 
and cloned twice by limiting dilution.  Selected clones were expanded; sodium 
azide was added  to medium to 0.05% and the  medium was stored  at 4"C. 
Hybridoma cells were frozen in complete medium containing  10% DMSO. 
F.LISA:  ELISAs were performed  using a Hybridoma Screening Kit (Be- 
thesda Research Laboratories, Gaithersburg,  MD) and Immulon II microtiter 
plates (Dynatech Corp., Alexandria, VA). Wells were coated for 2 h with  100 
#l of a 0.5 ug/ml solution of either the 45K or the 59K form of type X collagen 
in 0.1  M Na2CO3, 0.4 M NaCl, pH 8.5. Residual binding sites on the plate 
were blocked by a 2-h incubation  with  I l0 #l of a  1% BSA solution  in PBS, 
pH 7.8, followed by three more washes with PBS. All antibody dilutions, and 
collagen dilutions  for  inhibition  studies,  were  made  in  PBS  (pH  7.1) that 
contained  1%  BSA. Incubations  and washings during these assays were per- 
formed at room temperature  unless stated otherwise. Hybridoma antibodies 
(100 gl/well)  were incubated  with  type  X-coated  plates for  1 h at  250C or 
overnight at 4°C. Subsequent steps involving incubation  with the ~-galactosid- 
use-conjugated goat anti-mouse  igG and reaction with the p-nitrophenyl-~-o- 
galactoside substrate were performed according to the directions supplied with 
the screening kit. The absorbance of the wells at 414 nm was determined with 
an EL1SA plate reader (Bio-Tek Instruments.  Inc., Burlington, VT). 
Competition  EL1SAs  were performed with native collagen types I, It, III, IV, 
V,  lc~, 2a,  3~,  HMW-LMW,  and the two forms of type  X,  as well as the 
thermally  denatured  forms of type  X.  Type  I  collagen  was  purified  from 
lathyritic chick skin (5). Type iI and la, 2~, 3a collagens were isolated from a 
pepsin extract of adult chicken sternal cartilage (9) and separated by sequential 
precipitation from 0.5 M acetic acid at 0.9 M NaCl and 1.2 M NaCl, respectively 
(l l).  The  collagen types III, IV, and  V, isolated from chicken  gizzard, and 
H MW-LMW from sterna, were gifts of Richard Mayne (University of Alabama 
Medical School) ( l l ). The assays were performed under nonequilibrium  con- 
ditions (25). Aliquots of the collagen solutions were added to an equal volume 
of a  I: 100 dilution  of monoclonal  antibody-containing  culture  medium and 
incubated in a microfuge tube overnight at 4°C. A 100-#l aliquot of  the mixture 
was placed on type  X-coated  plates for 45  min.  Subsequent  steps were per- 
formed as described above. 
Competition ELISAs were also performed on the two forms of type X heated 
to progressively higher temperatures.  Aliquots of type X collagen (at 25 t~g/ml) 
were  heated  to  various  temperatures  for  30  min  in  a  Lauda  water  bath 
(Brinkmann  Instruments,  Inc., Westbury, NY). Triton X-100 was included in 
the assay of the 59K form at a final concentration  of 2% (see Results). Samples 
were  cooled  to  25*(? and  used  in  the  competition  ELISA  experiments  as 
described above. 
The susceptibility of the  type  X  collagen epitope  to a  purified  bacterial 
collagenase Form Ill [Advanced Biofactures Corp., Lynbrook, NY] was tested 
in ELISA. Type X collagen was preincubated with 100 U of  bacterial coUagenase 
for 100 t~g of collagen in 250 t~l ofS0 mM Tris, 0.2 M NaC1, l0 mM CaC12, 5 
mM N-ethylmaleimide, pH 7.5 buffer at 37"C for 18 h. The enzyme reaction 
was terminated  by the addition  of EDTA to 20 mM. 
Immunofluorescence  Observations:  various tissues  from em- 
bryonic and adult chickens were removed, frozen in dichlorodifluoromethane 
at dry-ice temperature,  and stored  at -70"C  until  needed.  Those  that were 
ossified were demineralized  for 3 d in 0.25 M EDTA at 4"C. Frozen tissues 
were embedded in Tissue-Tek II O.C.T. compound (Miles Laboratories, Inc., 
Elkart, IN) and 8-urn sections were cut with a cryostat. Sections were placed 
on  12-spot, albumenized  microscope  slides  (Shandon  Scientific,  Shandon 
Southern  Instruments,  Inc., Sewickley, PA). All cartilagenous tissue sections 
were pretreated for l h at 37"C with a 0.5% solution of testicular hyaluronidase 
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with PBS, and dried. In addition to the anti-type  X antibody,  adjacent sections 
were reacted with monoclonal  antibodies directed against either type I (26) or 
type II (27) collagen, which have been previously  described. Tissue sections 
were incubated with monoclonal  antibodies for 1 h and rinsed with PBS. The 
sections were then treated with rhodamine-conjugated  goat anti-mouse igG 
(Cappel Laboratories, Inc., CochranviUe, PA) for 1 h, rinsed with PBS, and 
mounted in glycerol-PBS  (95:5). Sections were examined using a Nikon Fluo- 
rophot equipped with an epi-illuminator  and a 590-nm filter. Photographs  were 
taken with Kodak Tri-X film rated at an ASA of 1600 and developed with 
Diafine (Acufine, Inc., Chicago, IL). 
RESULTS 
Monoclonal Antibody Production 
and Characterization 
To produce the desired  monoclonal antibodies,  we fused 
splenocytes from mice hyperimmunized with the 59K form 
of type X  collagen with NS-1 myeloma cells.  All 400 culture 
wells  showed positive  hybridoma growth in  hypoxanthine/ 
aminopterin/thymidine  selection  medium,  and  these  were 
screened  for the  production  of potentially desirable  mono- 
clonal antibodies by ELISA using plates coated with type X 
collagen.  12 were positive and four of these were cloned by 
limiting dilution. In preliminary immunofluorescence histo- 
chemical assays, the clones derived  from one original well, 
AC9, clearly produced a more intense fluorescent signal than 
those derived from any other original well. The monoclonal 
antibody produced by these clones was chosen for extensive 
characterization and subsequently for immunohistochemical 
localization studies. 
Medium  supernatants  from  AC9  cultures  reacted  with 
ELISA plates coated with either form of type X.  They had 
high antibody titers  and  still  gave a  positive reaction when 
diluted >2,000-fold (data not shown). By competition ELISAs 
in  which  the  plates  were  coated  with  the  45K  form,  the 
antibody  reacted  about  equally  well  with  both  molecular 
forms of type X, but not with any other native collagen type 
tested (Fig.  l). Most notably it did not react with type II, nor 
with the minor cartilage collagens including l a, 2a, 3a mol- 
ecules (10) and HMW-LMW (11). 
As can be seen  in Fig.  l,  the 59K form of type X  was a 
slightly less efficient inhibitor than was the 45K form. While 
this is undoubtedly due in part to the higher molecular weight 
of the 59K form, it may also reflect the tendency of this form 
of the molecule to aggregate when the nonhelical domain is 
present (17). In fact, in competition ELISA the 59K form of 
the molecule only showed a typical inhibition curve when it 
was reacted with the antibody in the presence of high concen- 
trations of nonionic detergent (2% Triton X- 100). If  detergent 
was not present in the reaction mixture,  an anomalous de- 
crease in inhibition was observed at higher concentrations of 
inhibitor collagen. (In Fig. 1, compare the curve generated by 
59K in the presence of Triton X-100, open squares, to that 
produced in its absence, asterisks.) 
The binding of the antibody to both forms of the molecule 
suggested that it was directed against an epitope within their 
common helical domain, as is generally found to be the case 
when  native collagens are  used to immunize  mice (28).  In 
addition,  bacterial  collagenase digestion  of type X  collagen 
completely abolished  the  ability  of the  molecule to  inhibit 
AC9 binding in ELISA (data not shown). We have previously 
demonstrated that a close correlation exists between the ther- 
mal denaturation temperature of the helix of a specific colla- 
gen type, as measured by CD spectropolarimetry, and the loss 
of monoclonal antibody binding, as determined by competi- 
tion ELISA (29, 30). This provides strong additional evidence 
that the antibody is directed against the collagen, in addition 
to defining one of the characteristics of the epitope. 
Samples of both the 45K and 59K forms of type X collagen 
were heated to progressively higher temperatures  at  neutral 
pH, allowed to cool to room temperature,  and then assayed 
for antibody binding by competition ELISA (for details see 
the legend for Fig. 2 and Materials and Methods). As can be 
seen in Fig. 2, the 45K form shows a sharp loss of antibody 
binding with a denaturation temperature (Tin) of 44"C. This 
is  ~3*  lower than  the  Tm determined  by CD spectropolar- 
imetry (23). Under identical conditions, the 59K form showed 
a different temperature  response, and appeared to lose only 
about  a  third  of its  total  inhibitory  ability.  This  probably 
reflects the rapid renaturation of a large portion of this form 
of the molecule upon being cooled to room temperature. This 
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FIGURE  1  Competition ELISA using antibody AC9 and various con- 
centrations of  native collagens as inhibitors. II,  the 45K  form  of 
type X collagen; *, the 59K form; [Z], the 59K form in the presence 
of 2% Triton X-IO0. Other collagen types including I (171), II (&), III 
(O),  IV (~), V (A), la, 2a, 3a (O), and HMW-LMW  NI,) showed no 
inhibition. 
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FIGURE  2  Thermal denaturation of the epitope recognized by the 
AC9 antibody, as measured by competition ELISA. The two forms 
of type X collagen were heated to various temperatures for 30 min 
and cooled to room temperature before incubation with the anti- 
body. 0, 45K form; II, the 59K form. Triton X-100 (2%) was included 
in the assay of the 59K form of type X collagen. 
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metric studies, and most probably is due to the presence of 
the nonhelical, globular domain which keeps the denatured 
chains in register (see Discussion). 
Immunohistochemical  Analyses 
For all immunohistochemical analyses,  cartilage sections 
were predigested with testicular hyaluronidase to remove po- 
tentially masking proteoglycans before reacting with antibod- 
ies  (7).  Tissues containing bone were also decalcified with 
EDTA to remove hydroxyapatite, which can also mask the 
antigenic sites of type I collagen (8). 
When the antitype X antibody was used to analyze unfixed 
cryostat sections of the distal half of the tibiotarsus from 13- 
d-old chick embryos (Fig. 3 B), the overall distribution of this 
molecule was found to be much more restricted than was that 
of type II collagen (Fig. 3 C), as evaluated by staining with a 
monoclonal  antibody specific  for that  collagen  type.  The 
region of the limb in which the cartilage matrix begins to 
show a  reaction for type X  is  slightly  behind the  front at 
which the chondrocytes have begun to hypertrophy (Fig.  3, 
arrowheads). This can be seen in Fig.  3 by comparing the 
location of the region of initiation of type X  reactivity with 
the front of newest bone formation in the surrounding per- 
iosteal sleeve, which is identified in Fig. 3A by the arrowhead. 
The section in Fig. 3A has been reacted with a monoclonal 
antibody against  type I  collagen, which brightly stains the 
bone in a trabecular pattern. Numerous studies have shown 
that the region of chondrocytes which undergo hypertrophy 
generally corresponds to, and can be demarcated by, the sleeve 
of periosteal bone which surrounds it (31-33). Strong reactiv- 
ity for type X extends uninterrupted to the edge of  the marrow 
cavity (Fig.  3 B, label mc), which is the terminal site where 
hypertrophied cells are removed. 
Fig. 3 B also indicates that type X collagen is present in the 
periosteal bone matrix, although the fluorescence  in this tissue 
is greatly diminished compared with that in the hypertrophic 
cartilage.  Note the light fluorescence in the periosteal layer of 
Fig.  3B (also  described later), compared with  its complete 
absence in the same region when reacted with the antitype II 
antibody (Fig. 3 C), which for this tissue serves as a negative 
control. 
The distribution  of type X  collagen in  the  extracellular 
matrices of endochondral bone is further illustrated in higher 
magnification fluorescence micrographs of the spongiosa of 
adult sternum shown in Fig. 4. The spongiosa characteristi- 
cally is composed of spicules of bone matrix deposited on the 
surface of a core of hypertrophied cartilage (calcified)  (34). 
Sections reacted with the antibody for type I collagen (Fig. 
4A) show bright fluorescence in the bone matrix and lightei 
fluorescence in the cartilage matrix. That the cartilage matrix 
in this region contains both collagen types I and II is consistent 
with the previous observations of von der Mark and vonder 
Mark (35). An adjacent tissue section reacted with antibody 
for type II collagen (Fig. 4 C) shows fluorescence only in the 
cartilagenous core within the spicule. The antitype X antibody 
(Fig. 4B) shows a composite picture in which both cartilage 
and  bone  are  reactive; the  cartilagenous  core  is  intensely 
fluorescent and the surrounding bone much less so. 
These results raised two questions.  Is  type X  present in 
cartilages that do not participate in endochondral bone for- 
mation and whose chondrocytes are therefore not destined to 
undergo hypertrophy? Is type X  found in other bones that 
form by intramembranous  ossification and  therefore have 
never been associated with a cartilagenous precursor? 
To answer the first question, we examined the tracheal and 
scleral  cartilages of 19-d embryos, neither of which partici- 
pates in endochondml bone formation. Fig. 5 shows the results 
obtained with tracheal rings,  which are cut in cross section. 
The cartilagenous matrix of these structures, which was sam- 
plied at several different sites along their circumference, was 
strongly reactive for type II collagen (Fig.  5 B), and the sur- 
rounding, fibrous perichondrium was reactive for type I (Fig. 
5A). Neither structure, however, showed detectable staining 
for type X collagen (Fig. 5 C). Similar results were observed 
with the seleral cartilage of the eye (data not shown). 
Membrane bones, however, did show reactivity for type X. 
Fig.  6 shows serial  sections of a  19-d embryonic calvarium 
treated with antibody for type I (Fig. 6A), type X (Fig. 6B), 
and type II (Fig. 6 C). The reactivity for type X is much less 
than for type I, and this intensity can vary somewhat in bone 
from different sources and ages of  embryos. In all experiments 
we have tried, however, the fluorescence signal for type X is 
noticeably brighter than that obtained with the antitype II 
antibody which serves as a negative control. Similar patterns 
of reactivity and  fluorescent intensities were also  obtained 
when adult (8 wk) chicken calvaria were examined (data not 
shown). As additional controls (not shown), parallel sections 
of  bone were reacted with other monoclonal antibodies whose 
specificities should have precluded their staining of  this tissue, 
including one antibody specific for lens fiber cells and another 
directed against type IV collagen. These antibodies were all 
equally  negative.  Also,  the  reaction  for type  X  could  be 
completely eliminated by prereacting the antibody with an 
excess of 45K collagen. Another antitype X collagen mono- 
clonal antibody, which we do not routinely employ since it 
appears to have a  low affinity, reacted with bone, but less 
strongly than did AC9. 
The tissue distribution of type X  collagen appears to be 
exclusive to the skeletal system. Type X is detected near the 
hypertrophic cells of other cartilagenous tissues that undergo 
endochondral bone formation, including embryonic vertebrae 
and the cephalic aspect of the sternum (Schmid, T. M., E. 
Gibney, and T. F. Linsenmayer, manuscript in preparation). 
However, we have not found immunohistochemically detect- 
able amounts in sections of nonskeletal tissues we have ex- 
amined,  including cornea, sclera,  skin,  large  blood vessels, 
heart, skeletal muscle, brain,  and as already described, the 
trachea. 
DISCUSSION 
The data we have obtained with monoclonal antibody AC9 
against type X  collagen corroborate our earlier biochemical 
evidence suggesting that this molecule is a unique genetic type 
(12). The data are also consistent with our previous radiola- 
beling experiments (3,  16) which suggested  that in cartilage 
the molecule is present only in the hypertrophic zone. 
By a number of criteria, we have observed that monoclonal 
antibody AC9  is specific for type X  collagen and that the 
epitope against which it is directed is conformation dependent 
and located within the helical domain. By competition ELISA 
it did not react with any other collagen type tested, which 
included other types currently known to exist in cartilage. 
The assignment of  the epitope to the helical domain was made 
by several criteria, including: (a) its reactivity with both the 
45K and 59K forms, whose structural common denominator 
SCHMID AND  LINSENMAYER  Localization of Type X Collagen  601 FIGURE 3  Photomicrographs of distal half of 13-d chick embryo tibiotarsus treated with monoclonal antibodies directed against 
collagen types  I (A), X (B), and II (C). Arrowheads mark the distal boundary of hypertrophic chondrocytes.  The marrow cavity 
(mc) and epiphysis (e) are labeled, x  26. 
is the helical domain; (b) the ability of highly purified bacterial 
collagenase to abolish reactivity; and (c) the correlation ob- 
served between antibody binding and the thermal denatura- 
tion-renaturation  properties  of the  different  forms  of the 
molecule. 
The data obtained here in the thermal denaturation exper- 
602  THE JOURNAL OF  CELL BIOLOGY . VOLUME  100,  1985 FIGURE  4  Photomicrographs of adult chicken  sternum (7 wk) re- 
acted with monoclonal antibodies directed against collagen types I 
(A),  X  (B),  and  II  (C).  Tissues  were  dissected  from  the  calcified 
portion of the sternum and decalcified in EDTA for 1 wk. x  100. 
iments in all respects fit with those we previously obtained by 
monitoring the ellipticities of the  molecules in the spectro- 
polarimeter (23). The thermal denaturation curve of the 45K 
form as measured by competition ELISA generally paralleled 
that which we had previously obtained by CD spectropolar- 
imetry. The  Tr,  obtained from the thermal denaturation  of 
the epitope (44"C) was -3"C lower than the Tm (47"C) of the 
entire molecule as measured by changes in its ellipticity. This 
difference is somewhat greater than we previously observed 
for similar correlations made for type V  collagen  and  two 
different monoclonal antibodies specific for it (30).  Possibly, 
the  epitope against which  AC9  is directed  has a  somewhat 
FIGURE  5  Photomicrographs of serial sections of 19-d embryonic 
chick trachea treated with monoclonal antibodies directed against 
collagen types I (A), II (B), and X (C). x  100. 
lower thermal stability than that of  the overall helical structure 
of the type X molecule, which is the parameter that would be 
measured by CD spectropolarimetry. The 59K form exhibited 
a different denaturation profile. It appeared to lose only about 
one third of its total inhibitory ability, even at the  highest 
temperatures examined. We are quite sure, however, that this 
result was due to rapid renaturation of a large portion of the 
denatured  59K molecules, since it is both qualitatively and 
quantitatively in good agreement with our previous CD anal- 
yses on this form of the molecule. In those experiments, we 
observed that  when  a  sample of thermally denatured  59K 
molecules was cooled to room temperature, as was done in 
the  ELISA  experiments,  about  two  thirds  of the  original 
helical signal  returned  within  40  rain.  Since the  45K form 
showed no detectable renaturation, as was also the case here, 
most likely renaturation in the 59K form is due to the presence 
SCHMID AND LINSENMAYER Localization of Type X Collagen  603 FIGURE 6  Photomicrographs of serial sections of 19-d embryonic 
chick calvaria treated with monoclonal antibodies directed against 
collagen types I (A), X (B), and II (C). x  100. 
of the  nonhelical  domain, which  we know to be thermally 
stable (23).  This probably keeps the chains of the denatured 
molecules in  register, thus promoting rapid reformation of 
the helical structure upon cooling. Similar rapid renaturation 
has been reported for procollagen type I, which has a thermally 
stable nonhelical domain (36). 
We have recently demonstrated (37) that anticollagen mon- 
oclonal  antibodies  that  recognize  conformation-dependent 
helical epitopes can  serve as specific immunohistochemical 
probes for changes in this molecular conformation in tissues 
in situ. By using this approach, we were able to demonstrate 
that the  T,, of the epitope of type IV collagen in basement 
membranes  is  15-20"C  higher  in  situ  than  that  which  is 
measured in solution (29). The conformation-dependent char- 
acter of antibody AC9, as demonstrated here, should make it 
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a useful probe for similar studies on the in situ structure and 
assembly of type X collagen. 
Our  immunohistochemical  analyses suggest  that  type  X 
collagen is a  skeletal-specific molecule and, as demonstrated 
here,  may  be  present  in  bone  as  well  as  in  hypertrophic 
cartilage.  All  of the  controls,  as  described  in  Results,  are 
consistent with this binding being specific. However, as judged 
by  the  fluorescent  signal  produced,  it  may  be  present  in 
exceedingly  small  amounts.  This  conclusion  must  remain 
tentative since,  in  preliminary attempts, we have not  been 
able to extract identifiable quantities of type X from calvaria. 
Thus, we can not say for certain that the epitope detected in 
bone belongs to the same type X molecule present in cartilage; 
it may be in another, closely related one. 
In cartilage, the overall staining pattern obtained is consist- 
ent with the molecule being exclusively a  product of hyper- 
trophic  cartilage.  It is  not  found  in  cartilages that  do  not 
undergo hypertrophy. We have also observed that throughout 
embryonic development of the tibiotarsus, the temporal and 
spatial distribution of type X  collagen is consistent with this 
conclusion (38). Thus the process ofchondrocyte hypertrophy 
does  not  simply involve quantitative changes  in  the  same 
battery of matrix molecules the cells had been synthesizing at 
an earlier phase in their life cycle, as might be the case if the 
cells were simply shutting down their biosynthetic machinery 
in preparation for their eventual removal. Instead, hypertro- 
phy seems to  be an  active process,  involving the  de  novo 
synthesis of  at least one qualitatively different macromolecule. 
Thus far we have not observed detectable amounts of type 
X collagen in any location outside of the skeletal system. But 
such a conclusion must always be considered as tentative until 
all  possible adult  and  embryonic tissue  sources  have been 
examined, and at all stages of development. Type II collagen, 
for example, once thought to be found exclusively in cartilage, 
has been found in both the vitreous of the eye and the avian 
primary corneal stroma. In the latter structure, it is synthe- 
sized only in very young embryos (39). Also, masked antigenic 
sites are always a possibility (30). 
We can only speculate as to what role(s) type X  collagen 
performs in  the  skeletal  system.  Its high  concentration  in 
hypertrophic cartilage suggests  that  it might be involved in 
the processes of matrix erosion, vascularization, or calcifica- 
tion, all of which occur in this region. Its presence in  bone 
was somewhat unexpected, since the extracellular matrices of 
bone and cartilage are dramatically different. They do, how- 
ever, have one  common feature  in  the  presence of matrix 
vesicles (40,  41),  which are thought to be the initial sites of 
hydroxyapatite formation (42,  43).  Whether or not  type X 
collagen is associated with these structures, or acts in concert 
with  them  in  the  process  of calcification,  is  an  interesting 
possibility which we are pursuing. 
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